News

Net profit of Astal Laboratories rose 180.29% to Rs 7.68 crore in the quarter ended March 2026 as against Rs 2.74 crore during the previous quarter ended March 2025. Sales rose 471.15% to Rs 134.05 crore in the quarter ended March 2026 as against Rs 23.47 crore during the previous quarter ended March 2025.For the full year,net profit rose 64.73% to Rs 14.71 crore in the year ended March 2026 as against Rs 8.93 crore during the previous year ended March 2025. Sales rose 287.87% to Rs 249.13 crore in the year ended March 2026 as against Rs 64.23 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales134.0523.47 471 249.1364.23 288 OPM %7.6017.81 -8.3419.88 - PBDT9.203.95 133 18.9612.20 55 PBT8.343.85 117 17.7311.98 48 NP7.682.74 180 14.718.93 65 Powered by Capital Market - Live News

Astal Laboratories will hold a meeting of the Board of Directors of the Company on 30 May 2026.

Astal Laboratories will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live News

Net profit of Astal Laboratories rose 29.00% to Rs 2.58 crore in the quarter ended September 2025 as against Rs 2.00 crore during the previous quarter ended September 2024. Sales rose 185.11% to Rs 37.52 crore in the quarter ended September 2025 as against Rs 13.16 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales37.5213.16 185 OPM %10.2921.96 - PBDT3.582.80 28 PBT3.462.77 25 NP2.582.00 29 Powered by Capital Market - Live News

Astal Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News